Variant report
Variant | esv3485561 |
---|---|
Chromosome Location | chr11:32388235-32392721 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:32392237..32394630-chr11:32604009..32606559,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000149100 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185345641 | chr11:32388240-32388241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577894315 | chr11:32388260-32388261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115258957 | chr11:32388280-32388281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs57722468 | chr11:32388313-32388314 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs529211145 | chr11:32388327-32388328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542963110 | chr11:32388412-32388413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562763864 | chr11:32388436-32388437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531663626 | chr11:32388463-32388464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368043239 | chr11:32388482-32388483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551448506 | chr11:32388488-32388489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs56911719 | chr11:32388502-32388503 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs527876296 | chr11:32388539-32388540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549189569 | chr11:32388555-32388556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576708466 | chr11:32388576-32388577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs367703434 | chr11:32388579-32388580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs373643044 | chr11:32388585-32388586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150628826 | chr11:32388619-32388620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs58736369 | chr11:32388627-32388628 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs189923503 | chr11:32388635-32388636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555313823 | chr11:32388636-32388637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575852923 | chr11:32388677-32388678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs58222320 | chr11:32388682-32388683 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs552693907 | chr11:32388697-32388698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs117209163 | chr11:32388748-32388749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577857460 | chr11:32388752-32388753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540418570 | chr11:32388781-32388782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111884735 | chr11:32388797-32388798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541181174 | chr11:32389620-32389621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs191495387 | chr11:32389652-32389653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs149023207 | chr11:32389678-32389679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs141038715 | chr11:32389679-32389680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530794964 | chr11:32389739-32389740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182590832 | chr11:32389753-32389754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs117022287 | chr11:32389818-32389819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7118515 | chr11:32389847-32389848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551220909 | chr11:32389943-32389944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551347117 | chr11:32389993-32389994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142064233 | chr11:32389996-32389997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554952809 | chr11:32392244-32392245 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs6484573 | chr11:32392251-32392252 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs548901544 | chr11:32392270-32392271 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs573961478 | chr11:32392312-32392313 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs548444962 | chr11:32392343-32392344 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs7951745 | chr11:32392395-32392396 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs542611025 | chr11:32392403-32392404 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs537435576 | chr11:32392431-32392432 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs551007208 | chr11:32392441-32392442 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs570912149 | chr11:32392472-32392473 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs79470491 | chr11:32392476-32392477 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs61889205 | chr11:32392482-32392483 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21364760 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Aniridia syndrome | 21572526 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Denys-drash syndrome | 21085971 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
WAGR syndrome | 16773131 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Aniridia syndrome | 17204608 | CNVD |
Mental retardation | 17204608 | CNVD |
WAGR syndrome | 19617690 | CNVD |
genitourinary abnormalities | 17204608 | CNVD |
Breast cancer | 16397240 | CNVD |
Mental retardation | 16773131 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17160897 | CNVD |
Cancer | 21183584 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
WAGR syndrome | 22470819 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Denys-drash syndrome | 19566914 | CNVD |
Familial wilms tumor | 19566914 | CNVD |
Frasier syndrome | 19566914 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
WAGR syndrome | 20603712 | CNVD |
Autism | 17322880 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21858162 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Wilms tumour | 17204608 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 17440070 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:32387800-32388600 | Enhancers | Ovary | ovary |
2 | chr11:32388000-32388800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr11:32388200-32388600 | Enhancers | Adipose Nuclei | Adipose |
4 | chr11:32388200-32388800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr11:32388200-32388800 | Enhancers | HepG2 | liver |
6 | chr11:32389600-32390000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |